---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-011579"
form_type: "8-K"
ticker: null
cik: "0001621227"
company_name: "Adaptimmune Therapeutics PLC"
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:12:37.573569+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Adaptimmune receives Nasdaq delisting notice due to low bid price; intends to request hearing

## Summary
- Nasdaq determined ADAP's closing bid price was $0.10 or less for 10 consecutive trading days as of Aug 12, 2025.
- Company is subject to delisting under Low Priced Stocks Rule unless it requests a hearing; it intends to do so.
- Delisting action stayed pending hearing and any extension granted by Nasdaq Hearings Panel; ADSs continue trading.
- Company previously had until Oct 27, 2025 to regain $1.00 bid compliance; new rule triggers separate delisting process.

## SEC filing metadata
- accession: 0001558370-25-011579
- form_type: 8-K
- cik: 0001621227
- company_name: Adaptimmune Therapeutics PLC
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621227/000155837025011579/0001558370-25-011579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621227/000155837025011579/adap-20250814x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-011579
- JSON: https://secwatch.observer/filing/0001558370-25-011579.json
- Plain text: https://secwatch.observer/filing/0001558370-25-011579.txt

## Key facts
- Listing & Compliance Notices
  Adaptimmune Therapeutics PLC received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5810(c)(3)(A)(iii)
  source text: August 14, 2025, Nasdaq issued a letter to the Company that as of August 12, 2025, it determined that the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule” together with the Rule, the “Rules”) and its securities are subject to delisting from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). Accordingly, the Company intends to timely request a hearing and therefore ex
  evidence_url: https://www.sec.gov/Archives/edgar/data/1621227/000155837025011579/0001558370-25-011579-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.